Suzuki Takeshi | Department Of Internal Medicine And Cardiology Tama-nagayama Hospital Nippon Medical School
スポンサーリンク
概要
- SUZUKI Takeshiの詳細を見る
- 同名の論文著者
- Department Of Internal Medicine And Cardiology Tama-nagayama Hospital Nippon Medical Schoolの論文著者
関連著者
-
Kanazawa Hiromi
日本医科大学 内科学第一
-
Kishida H
Department Of Internal Medicine Division Of Cardiology Nippon Medical School
-
Kishida Hiroshi
日本医科大学 循環器内科
-
Kishida Hiroshi
Department Of Cardiology Nippon Medical School Tama-nagayama Hospital
-
Hoshino Kimihiko
First Department Of Internal Medicine Nippon Medical School
-
Kishida Hioroshi
1st Department Of Internal Medicine Nippon Medical School
-
Kishida Hiroshi
Division Of Cardiology Hepatology Geriatrics And Integrated Medicine Department Of Internal Medicine
-
Kishida Hiroshi
First Dept.of Intern. Med. Nippon Medical School
-
Suzuki Takeshi
Department Of Internal Medicine And Cardiology Tama-nagayama Hospital Nippon Medical School
-
Kishida Hiroshi
Division Of Cardiology Hepatology Geriatrics And Integrated Medicine Department Of Internal Medicine
著作論文
- Vasodilatory Effect of Subsequent Administration of Fasudil, a Rho-Kinase Inhibitor, Surpasses That of Nitroglycerin at the Concentric Coronary Stenosis in Patients With Stable Angina Pectoris
- Fasudil, a Rho-Kinase Inhibitor, Has Potent Vasodilator Effect at Diseased Coronary Segments
- β-Blocker Treatment Is Associated with Physical Aspect of Quality of Life in Out-of-Hospital Patients with Myocardial Infarction
- HMG-CoA Reductase Inhibitors (Statins) Attenuate In-Stent Intimal Proliferation : Relative Contributions of Lipid-Lowering Effect and Anti-Inflammatory Action
- PJ-493 Relationship between the Mismatch of TI-201 and I-123-BMIPP Myocardial SPECT and Autonomic Function in Patients with Acute Myocardial Infarction(Autonomic nervous system-5 (H) PJ83,Poster Session (Japanese),The 70th Anniversary Annual Scientific Me
- Rho/Rho-kinase System Contributes to Vasomotor Function in Moderate-grade Coronary Stenotic Lesions
- Fast Fourier transform (FFT) analysis of the effects of epalrestat, an aldose reductase inhibitor, on autonomic function in diabetic patients